These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1378132)

  • 1. Multiple action agents in cardiovascular therapy. Satellite symposium to the 5th European Meeting on Hypertension. Milan, Italy, June 11, 1991.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S1-146. PubMed ID: 1378132
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure and the therapy of advanced heart failure.
    Cohn JN
    J Am Coll Cardiol; 2004 Apr; 43(8):1430-1. PubMed ID: 15093879
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple action compounds in angina pectoris.
    Kelly DT; Freedman SB
    Z Kardiol; 1989; 78 Suppl 3():16-20. PubMed ID: 2573212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol use in heart failure.
    Neal CP; Kendrach MG
    Ann Pharmacother; 1998 Mar; 32(3):376-81. PubMed ID: 9533068
    [No Abstract]   [Full Text] [Related]  

  • 6. Refining the Logic of Antihypertensive Therapy: An International Symposium on Carvedilol. Paris, France, October 19, 1990.
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S1-67. PubMed ID: 8098063
    [No Abstract]   [Full Text] [Related]  

  • 7. [Carvedilol in cardiac decompensation].
    Dib J
    Rev Med Liege; 1996 Feb; 51(2):198-200. PubMed ID: 8650455
    [No Abstract]   [Full Text] [Related]  

  • 8. Carvedilol for anthracycline cardiomyopathy prevention.
    Florenzano F; Salman P
    J Am Coll Cardiol; 2007 May; 49(21):2142; author reply 2142-3. PubMed ID: 17531665
    [No Abstract]   [Full Text] [Related]  

  • 9. [Carvedilol therapy in pediatric patients with Takayasu's arteritis complicated with congestive heart failure: a case report].
    Wu XY; Song HM; Wei M
    Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):315-6. PubMed ID: 19555579
    [No Abstract]   [Full Text] [Related]  

  • 10. Vasodilating versus first-generation β-blockers for cardiovascular protection.
    Fares H; Lavie CJ; Ventura HO
    Postgrad Med; 2012 Mar; 124(2):7-15. PubMed ID: 22437211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of carvedilol, slow-release nifedipine, and atenolol in the management of essential hypertension.
    Hall S; Prescott RI; Hallman RJ; Dixon S; Harvey RE; Ball SG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S35-8. PubMed ID: 1721977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol--A new nonselective beta blocker.
    Forrest E; Stanley A; Hayes P
    Hepatology; 2000 Mar; 31(3):809-11. PubMed ID: 10722317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol. Results of a randomised study].
    Latini R
    Ital Heart J Suppl; 2001 Jun; 2(6):692-3. PubMed ID: 11460849
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertension in the spectrum of cardiovascular disease.
    J Hypertens Suppl; 1993 Jun; 11(4):S1-89. PubMed ID: 8104237
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical efficacy of carvedilol in severe hypertension.
    Ogihara T; Yoshinaga K; Kamahara Y; Ikeda M; Goto Y; Arakawa K; Iimura I; Ishii M; Kokubu T; Takeda T
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-effect relationship of carvedilol in essential hypertension. An open study.
    Ogihara T; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T; Arakawa K
    Drugs; 1988; 36 Suppl 6():75-81. PubMed ID: 2908305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol: a new approach to antihypertensive therapy. Proceedings from International Symposium on Carvedilol. Berlin, March 14-17, 1991.
    Clin Investig; 1992; 70 Suppl 1():S1-131. PubMed ID: 1350477
    [No Abstract]   [Full Text] [Related]  

  • 18. Major heart failure news from 2001.
    Francis D
    Heart Fail Monit; 2002; 2(4):147-8. PubMed ID: 12638556
    [No Abstract]   [Full Text] [Related]  

  • 19. Carvedilol improves endothelium-dependent vasodilation in patients with dilated cardiomyopathy.
    Nishioka K; Nakagawa K; Umemura T; Jitsuiki D; Ueda K; Goto C; Chayama K; Yoshizumi M; Higashi Y
    Heart; 2007 Feb; 93(2):247-8. PubMed ID: 17228074
    [No Abstract]   [Full Text] [Related]  

  • 20. Carvedilol reverses elevated pulmonary vascular resistance in a child with dilated cardiomyopathy.
    Horenstein MS; Ross RD; Singh TP; Epstein ML
    Pediatr Cardiol; 2002; 23(1):100-2. PubMed ID: 11922497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.